Skip to content

Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer

Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01828502
Enrollment
0
Registered
2013-04-10
Start date
2013-10-31
Completion date
2016-06-30
Last updated
2014-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Cancer

Keywords

Cotinine, Secondhand Smoke Exposure (SHSE), Secondhand Smoke (SHS)

Brief summary

RATIONALE: Providing parent/caregivers of children with cancer with education and evidence of secondhand smoke exposure can protect the child from future exposure to tobacco smoke. PURPOSE: This randomized study will compare education only to education plus cotinine feedback in decreasing secondhand smoke exposure in pediatric patients with cancer that reside with a household smoker.

Detailed description

OBJECTIVES: The primary objective of this study is to determine if providing urine cotinine feedback to caregivers in conjunction with standard education will be more effective than education alone in reducing patient SHS exposure. The secondary objectives of this study are: To determine whether urine cotinine feedback in conjunction with education provided to the caregiver is more effective in changing parental smoking behavior compared to education alone. As an exploratory measure we will collect history and physical exam data to follow patient's clinical complications during the study to determine if patients with a decrease in SHS exposure also have a decrease in clinical complications.

Interventions

BEHAVIORALEducation

Participants in both groups will receive education by the EPA on the danger of exposure to secondhand smoke and how exposure can be prevented.

BEHAVIORALCotinine Education

Those randomized to the active intervention will also be provided with education utilizing the cotinine test strip in conjunction with the education from the EPA.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of South Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 2 years and ≤ 12 years at the time of study entry. * Currently undergoing treatment for cancer at the time of enrollment, at least 28 days post diagnosis. * The child must reside 5 days a week with a household smoker (defined as a person who smokes greater than 10 cigarettes daily). * Child must be potty trained. * Parent/Legal Guardian ≥ 18 years of age. * Parent/Legal Guardian who accompanies the child to the first visit must accompany the child to all other visits. This person does not need to be the household smoker, but must be willing to educate the smoker on results at the visit and take the education handout home to them. * Parent/Legal Guardian must have a working phone to complete the week 5 follow-up phone call. * Able and willing to sign informed consent/assent. * Signed HIPAA compliant research authorization.

Exclusion criteria

* Planned hospitalization within 3 days of any scheduled study visit (due to the urine cotinine measurement representing the previous 48-72 hours of tobacco exposure. * Inability to perform the initial cotinine test.

Design outcomes

Primary

MeasureTime frameDescription
Change in urine cotinine level4 weeks after baseline visitThe primary objective of this study is to determine if providing urine cotinine feedback to caregivers in conjunction with standard education will be more effective than education alone in reducing patient SHS exposure.

Secondary

MeasureTime frameDescription
Change in Self-Reported Smoking Behavior4 weeks after baseline visitTo determine whether urine cotinine feedback in conjunction with education provided to the caregiver is more effective in changing parental smoking behavior compared to education alone.
Number of medical complications4 weeks after baseline visitAs an exploratory measure we will collect history and physical exam data to follow patient's clinical complications during the study to determine if patients with a decrease in SHS exposure also have a decrease in clinical complications.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026